Abstract
The role of low penetrance genes and environmental factors in the etiology of bladder cancer (CaB) is unclear, but may involve genetic and environmental factors. Most environmental pro-carcinogens require metabolic activation by phase I enzymes (CYP450s), However, phase II enzyme (i.e., microsomal epoxide hydrolase: mEH) is mainly involved in the detoxification of wide variety of endogenous or exogenous carcinogens. Genetic differences in CYP1A1 gene and the mEH gene polymorphisms have been reported to be associated with susceptibility to various cancers. In our case–control study, we assess whether Msp1 polymorphism of CYP1A1 (CYP1A1*2A), and His113 in exon 3 and Arg139 in exon 4 of the mEH susceptibility genotypes, tobacco-use and age factors contribute to bladder cancer risk among Indians. A case–control study was conducted in 106 bladder cancer (CaB) patients and 160 age matched controls from similar ethnic background. The CYP1A1*2A and mEH genotypes were determined by polymerase chain reaction/restriction fragment length polymorphism method from DNA extracted from peripheral blood samples. Binary logistic regression model was used for assessing differences in genotype prevalence between patients and the controls. The Arlequin software package was used to compute haplotype frequencies. We observed non-significant association in T/C polymorphism of the CYP1A1 gene (CYP1A1*2A); however, the exon 3 His genotype of the mEH gene polymorphism alone (odds ratio = 2.67, P = 0.001) or in combination with tobacco-users were significantly associated with the risk of bladder cancer. No associations were observed with stage or grade of bladder tumor with these genotypes. In conclusion, our study demonstrated that exon 3 His genotype of the mEH are more prone to the risk of sporadic bladder cancer in North India.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bale AE, Nebert DW, McBride OW (1987) Subchromosomal localization of the dioxin-inducible P1450 locus (CYP1) and description of two RFLPs detected within a 3’ P1450 cDNA probe. Cytogenet Cell Genet 46:574–575
Brockmoller J, Cascorbi I, Kerb R, Roots I (1996) Combined analysis of inherited polymorphisms in arylamine N-acetyltransferase 2, glutathione S-transferases M1 and T1, microsomal epoxide hydrolase, and cytochrome P450 enzymes as modulators of bladder cancer risk. Cancer Res 56:3915–3925
Casson AG, Zheng Z, Porter GA, Guernsey DL (2006) Genetic polymorphisms of microsomal epoxide hydroxylase and glutathione S-transferases M1, T1 and P1, interactions with smoking, and risk for esophageal (Barrett) adenocarcinoma. Cancer Detect Prev 30(5):423–431
Crofts F, Taioli E, Trachman J, Cosma GN, Currie D, Toniolo P, Garte SJ (1994) Functional significance of different human CYP1A1 genotypes. Carcinogenesis 15:2961–2963
Dorrenhaus A, Muller T, Roos PH (2007) Increased CYP1A1 expression in human exfoliated urothelial cells of cigarette smokers compared to non-smokers. Arch Toxicol 81(1):19–25
Gsur A, Zidek T, Schnattinger K, Feik E, Haidinger G, Hollaus P, Mohn-Staudner A, Armbruster C, Madersbacher S, Schatzl G, Trieb K, Vutuc C, Micksche M (2003) Association of microsomal epoxide hydrolase polymorphisms and lung cancer risk. Br J Cancer 89(4):702–706
Hassett C, Aicher L, Sidhu JS, Omiecinski CJ (1994) Human microsomal epoxide hydrolase: genetic polymorphism and functional expression in vitro of amino acid variants. Hum Mol Genet 3:421–428
Jacquet M, Lambert V, Baudoux E, Muller M, Kremers P, Gielen J (1996) Correlation between P450 CYP1A1 inducibility, MspI genotype and lung cancer incidence. Eur J Cancer 32:1701–1706
Johns LE, Houlston RS (2000) Glutathione S-transferase mu (GSTM1) status and bladder cancer risk: a meta analysis. Mutagenesis 15:399–404
Jourenkova-Mironova N, Mitrunen K, Bouchardy C, Dayer P, Benhamou S, Hirvonen A (2000) High-activity microsomal epoxide hydrolase genotypes and the risk of oral, pharynx, and larynx cancers. Cancer Res 60(3):534–536
Kiss I, Orsós Z, Gombos K, Bogner B, Csejtei A, Tibold A, Varga Z, Pázsit E, Magda I, Zölyomi A, Ember I (2007) Association between allelic polymorphisms of metabolizing enzymes (CYP 1A1, CYP 1A2, CYP 2E1, mEH) and occurrence of colorectal cancer in Hungary. Anticancer Res 27(4C):2931–2937
Kogevinas M, ‘t Mannetje A, Cordier S, Ranft U, Gonzalez CA, Vineis P, Chang-Claude J, Lynge E, Wahrendorf J, Tzonou A, Jockel KH, Serra C, Porru S, Hours M, Greiser E, Boffetta P (2003) Occupation and bladder cancer among men in Western Europe. Cancer Causes Control 14:907–914
Lancaster JM, Browniee HA, Bell DA, Futreal A, Marks JR, Berchuck A, Wiseman RW, Taylor JA (1996) Microsomal epoxide hydrolase polymorphism as a risk factor for ovarian cancer. Mol Carcinog 17:160–162
Lin YC, Wu DC, Lee JM, Hsu HK, Kao EL, Yang CH, Wu MT (2006) The association between microsomal epoxide hydrolase genotypes and esophageal squamous-cell-carcinoma in Taiwan: interaction between areca chewing and smoking. Cancer Lett 237(2):281–288
McGlynn KA, Rosvold EA, Lustbader ED, Hu Y, Clapper ML, Zhou T, Wild CP, Xia XL et al (1995) Susceptibility to hepatocellular carcinoma is associated with genetic variation in the enzymatic detoxification of aflatoxin B1. Proc Natl Acad Sci USA 92:2384–2387
Mittal RD, Srivastava DS (2007) Cytochrome P4501A1 and microsomal epoxide hydrolase gene polymorphisms, gene-environmental interaction and risk of prostate cancer. DNA Cell Biol 26(11):791–798
Murai T, Mori Y, Tatematsu K, Koide A, Hagiwara A, Makino S, Mori S, Wanibuchi H, Fukushima S (2005) Differences in susceptibility to N-butyl-N-(4-hydroxybutyl) nitrosamine-induced urinary bladder carcinogenesis between SD/gShi rats with spontaneous hypospermatogenesis and SD/cShi rats with spontaneous hydronephrosis. Cancer Sci 96(10):637–644
Murray GI, Taylor VE, McKay JA, Weaver RJ, Ewen SW, Melvin WT, Burke MD (1995) Expression of xenobiotic metabolizing enzymes in tumours of the urinary bladder. Int J Exp Pathol 76:271–276
Norppa H (2004) Cytogenetic biomarkers and genetic polymorphisms. Toxicol Lett 149:309–334
Pastorelli R, Guanci M, Cerri A, Negri E, La Vecchia C, Fumagalli F, Mezzetti M, Cappelli R, Panigalli T, Fanelli R, Airoldi L (1998) Impact of inherited polymorphisms in glutathione S-transferase M1, microsomal epoxide hydrolase, cytochrome P450 enzymes on DNA, and blood protein adducts of benzo(a)pyrene-diolepoxide. Cancer Epidemiol Biomarkers Prev 7:703–709
Salama SA, Sierra-Torres CH, Oh HY, Hamada FA, Au WW (2001) Variant metabolizing gene alleles determine the genotoxicity of benzo[a]pyrene. Environ Mol Mutagen 37:17–26
Sambrook J, Fritsch E, Maniatis T (1989) Molecular cloning-A laboratory manual, 2nd edn. Cold Spring Harbor Laboratory Press, Cold Spring Harbor
Silverman DT, Rothman N, Devesa SS (1999) Epidemiology of bladder cancer. In: Syrigos KN, Skinner DG (eds) Bladder cancer. Biology, diagnosis, management. Oxford University Press Inc., New York, pp 11–55
Smith CA, Harrison DJ (1997) Association between polymorphism in gene for microsomal epoxide hydrolase and susceptibility to emphysema. Lancet 350:630–633
Srivastava DS, Kumar A, Mittal B, Mittal RD (2004) Polymorphism of GSTM1 and GSTT1 genes in bladder cancer: a study from North India. Arch Toxicol 78:430–434
Srivastava DS, Mishra DK, Mandhani A, Kumar A, Mittal B, Mittal RD (2005) Association of genetic polymorphism of glutathione S-transferase M1, T1, P1 and susceptibility to bladder cancer. Eur Urol 48(2):339–344
Ulrich CM, Bigler J, Whitton JA, Bostick R, Fosdick L, Potter JD (2001) Epoxide hydrolase Tyr113His polymorphism is associated with elevated risk of colorectal polyps in the presence of smoking and high meat intake. Cancer Epidemiol Biomarkers Prev 10:875–882
Vineis P, Alavanja M, Garte S (2004) Dose-response relationship in tobacco-related cancers of bladder and lung: a biochemical interpretation. Int J Cancer 108:2–7
Weber WW (1997) Human drug metabolizing enzyme variants. In: Roberts Frazare JA, Carter CO (eds) Pharmacogenetics. Oxford University Press, London, pp 204–210
Wolf A, Kutz A, Plottner S, Behm C, Bolt HM, Follmann W, Kuhlmann J (2005) The effect of benzo(a)pyrene on porcine urinary bladder epithelial cells analyzed for the expression of selected genes and cellular toxicological endpoints. Toxicology 207:255–269
Young J (ed) (1997) Cancer incidence in five continents, vol VII. International Agency for Research on Cancer (IARC), Lyon, Scientific Publication 143
Acknowledgments
Dr Rama D Mittal conceived and designed the study, coordinated and supervised the entire study, wrote and edited the manuscript. DSL Srivastava performed the study, did the statistical analysis and drafted the manuscript. Dr Mandhani provided the clinical samples and helped in clinical evaluation of the patients. All authors read and approved the final manuscript. One of us (D.S.L. Srivastava) is thankful to Council of Scientific and Industrial Research, New Delhi, for awarding senior research fellowship.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Srivastava, D.S., Mandhani, A. & Mittal, R.D. Genetic polymorphisms of cytochrome P450 CYP1A1 (*2A) and microsomal epoxide hydrolase gene, interactions with tobacco-users, and susceptibility to bladder cancer: a study from North India. Arch Toxicol 82, 633–639 (2008). https://doi.org/10.1007/s00204-007-0276-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00204-007-0276-4